Skip to main content

UY Scuti Acquisition Corp.

For the period ended Jun 30, 2025. Filed Aug 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 6, 2025

UYSC$11.04+0.4%Stored close · as of Nov 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Statements of Changes in Shareholders’ Deficit (Unaudited)

**UNADUTIED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE MONTHS ENDED JUNE 30, 2025

Additional · Retained earnings · Total Shareholders’
Ordinary Shares · Paid-in · (Accumulated · Equity
SharesAmountCapitalDeficit)(Deficit)
Balance as of March 31, 20251,437,500$144$24,856$(163,268)$(138,268)
Proceeds allocated to Public Rights--5,387,388-5,387,388
Sale of private placement shares240,848242,408,456-2,408,480
Issuance of representative shares230,000232,112,577-2,112,600
Underwriters’ discount and other offering expenses--(3,264,646)-(3,264,646)
Accretion of ordinary share subject to redemption value--(1,970,381)-(1,970,381)
Net income---332,078332,078
Balance as of June 30, 2025 (Unaudited)1,908,348$191$4,698,250$168,810$4,867,251
(1)As a result of the underwriter’s full exercise of its over-allotment option on April 7 and April 9, 2025, no Founder Shares are currently subject to forfeiture as of June 30, 2025. (see Note 5)

FOR THE THREE MONTHS ENDED JUNE 30, 2024

Ordinary Shares · Additional Paid-in · Accumulated · Total Shareholders’ Equity
SharesAmountCapitalDeficit(Deficit)
Balance as of March 31, 20241,437,500$144$24,856$(6,748)$18,252
Net loss(30,000)(30,000)
Balance as of June 30, 2024 (Unaudited)1,437,500$144$24,856$(36,748)$(11,748)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.